OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 148 filers reported holding OCULAR THERAPEUTIX INC in Q2 2024. The put-call ratio across all filers is 3.05 and the average weighting 1.0%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 14,885,633 | $101,817,730 | 98.54% |
| ACUTA CAPITAL PARTNERS, LLC | 2,771,130 | $18,954,529 | 15.96% |
| Opaleye Management Inc. | 5,307,500 | $36,303,300 | 8.30% |
| VR Adviser, LLC | 12,762,462 | $87,295,240 | 5.56% |
| Rosalind Advisors, Inc. | 750,000 | $5,130,000 | 3.95% |
| TCG Crossover Management, LLC | 5,319,148 | $36,382,972 | 3.79% |
| DELTEC ASSET MANAGEMENT LLC | 2,590,265 | $17,717,413 | 3.39% |
| Logos Global Management LP | 5,150,000 | $35,226,000 | 2.86% |
| Octagon Capital Advisors LP | 2,425,000 | $16,587,000 | 2.61% |
| Deep Track Capital, LP | 12,721,460 | $87,014,786 | 2.60% |